Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 3/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.65 |
| ▸ | PRKCG | P05129 | 2/20 | 0.65 |
| ▸ | PRKCB | P05771 | 2/20 | 0.65 |
| ▸ | PRKCA | P17252 | 2/20 | 0.65 |
| ▸ | PRKCH | P24723 | 2/20 | 0.65 |
| ▸ | PRKCI | P41743 | 2/20 | 0.65 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.65 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.65 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.65 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.65 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.65 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | AKT1 | P31749 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25306967 | 1.00 | PRKD3 (0.65) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL116535 | 1.00 | PRKD3 (0.65) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL28622332 | 1.00 | PRKD3 (0.65) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Water SCHEMBL29707870 | 0.98 | PRKD3 (0.62) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Hydrochloric Acid SCHEMBL253903 | 0.98 | PRKD3 (0.61) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL5447359 | 0.98 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855786 | 0.98 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855744 | 0.98 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855768 | 0.98 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8855806 | 0.98 | PRKD3 (0.67) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707064-B2 | Methods of killing nematodes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-07-25 | — | — | US | claimed |
| US-20200323200-A1 | METHODS OF KILLING NEMATODES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2020-10-15 | — | — | US | claimed |
| EP-3105348-A1 | METHODS OF NUCLEIC ACID CAPTURE | Zymo Research Corporation (US) | 2016-12-21 | — | — | EP | claimed |
| WO-2015120447-A1 | METHODS OF NUCLEIC ACID CAPTURE | ZYMO RESEARCH CORPORATION (US) | 2015-08-13 | — | — | WO | claimed |
| EP-4148141-B1 | KIT FOR NUCLEIC ACID CAPTURE | ZYMO RES CORPORATION (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250270537-A1 | METHODS FOR NUCLEIC ACID CAPTURE | ZYMO RESEARCH CORPORATION (US) | 2025-08-28 | — | — | US | disclosed |
| US-11707064-B2 | Methods of killing nematodes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-07-25 | — | — | US | disclosed |
| US-20230127686-A1 | FATTY AMMONIUM SALT STARCH COMPLEXES AS PLANT WOUND PROTECTANTS AND ANTIMICROBIALS FOR WOUND DRESSINGS | US AGRICULTURE (US) | 2023-04-27 | — | — | US | disclosed |
| EP-4148141-A1 | KITS FOR NUCLEIC ACID CAPTURE | Zymo Research Corporation (US) | 2023-03-15 | — | — | EP | disclosed |
| US-11564393-B2 | Fatty ammonium salt starch complexes as antimicrobials, plant wound, and wood protectants | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-01-31 | — | — | US | disclosed |
| EP-3653723-B1 | METHODS FOR NUCLEIC ACID CAPTURE | ZYMO RES CORPORATION (US) | 2022-07-20 | — | — | EP | disclosed |
| US-20220186207-A1 | METHODS FOR NUCLEIC ACID CAPTURE | ZYMO RES CORPORATION (US) | 2022-06-16 | — | — | US | disclosed |
| EP-1721523-A2 | Aqueous pesticide formulations and novel surfactants | Monsanto Technology, LLC (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2006108672-A2 | PROCESS FOR IMPROVING THE INSULATING CAPACITY FOR EXPANDED VINYL AROMATIC POLYMERS AND THE PRODUCTS THUS OBTAINED | POLIMERI EUROPA S.P.A. (IT) | 2006-10-19 | — | — | WO | disclosed |
| EP-1343375-B1 | AQUEOUS PESTICIDE FORMULATIONS AND NOVEL SURFACTANTS | MONSANTO TECHNOLOGY LLC (US) | 2006-08-02 | — | — | EP | disclosed |
| US-7049270-B2 | Potassium glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2006-05-23 | — | — | US | disclosed |
| US-20050261130-A1 | Novel surfactants and formulations | MONSANTO TECHNOLOGY LLC (US) | 2005-11-24 | — | — | US | disclosed |
| EP-1343375-A2 | AQUEOUS PESTICIDE FORMULATIONS AND NOVEL SURFACTANTS | Monsanto Technology LLC (US) | 2003-09-17 | — | — | EP | disclosed |
| US-20030104943-A1 | Novel surfactants and formulations | MONSANTO TECHNOLOGY LLC | 2003-06-05 | — | — | US | disclosed |
| WO-2001089302-A2 | AQUEOUS PESTICIDE FORMULATIONS AND NOVEL SURFACTANTS | MONSANTO TECHNOLOGY, LLC (US) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261130-A1 | Novel surfactants and formulations | PHOSPHO1, GNMT, DDT | ACHE 74/4885PRKD3 639/4885PRKCG 157/4885 |
| US-20030104943-A1 | Novel surfactants and formulations | PHOSPHO1, GNMT, DDT | ACHE 104/4885PRKD3 622/4885PRKCG 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.